Erektil Disfonksiyon ve Kardiyometabolik Risk: Diyabet, Hipertansiyon, Obezite ve Endotel Disfonksiyonu
Özet
Erektil disfonksiyon (ED), yalnızca erkek cinsel sağlığını etkileyen bir bozukluk değil, aynı zamanda altta yatan kardiyometabolik hastalıkların erken klinik göstergelerinden biridir. Bu bölümde, erektil disfonksiyon ile diyabet, hipertansiyon, obezite, metabolik sendrom ve endotel disfonksiyonu arasındaki ilişkiler güncel bilimsel veriler ışığında ele alınmaktadır. Ereksiyon fizyolojisinde nitrik oksit–siklik guanozin monofosfat (NO–cGMP) yolağının rolü, oksidatif stresin endotelyal fonksiyonlar üzerindeki etkileri ve kardiyometabolik hastalıkların erektil fonksiyonları bozma mekanizmaları ayrıntılı olarak incelenmektedir. Ayrıca antihipertansif ilaçların cinsel fonksiyonlar üzerindeki etkileri, obeziteyle ilişkili hipogonadizm ve hormonal değişiklikler değerlendirilmektedir. Princeton IV Konsensüsü doğrultusunda erektil disfonksiyonu olan hastalarda kardiyovasküler risk değerlendirmesi ve uygun hasta yönetimi tartışılmaktadır. Tedavi kapsamında yaşam tarzı değişiklikleri, kilo kontrolü, fosfodiesteraz tip 5 inhibitörleri ve testosteron replasman tedavisinin yeri ele alınmaktadır. Bölüm, erektil disfonksiyonun değerlendirilmesi ve tedavisinde kardiyometabolik risk faktörlerinin bütüncül biçimde ele alınmasının ve multidisipliner yaklaşımın önemini vurgulamaktadır.
Referanslar
Salonia A, Bettocchi C, Capogrosso P, Corona G, Minhas S, Serefoglu EC, et al. Sexual and Reproductive Health. EAU Guidelines. Arnhem, The Netherlands: EAU Guidelines Office; 2026.
Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW. Erectile Dysfunction: AUA Guideline. J Urol. 2018 Sep;200(3):633-641. doi: 10.1016/j.juro.2018.05.004. Epub 2018 May 7. Erratum in: J Urol. 2022 Mar;207(3):743. doi: 10.1097/JU.0000000000002389. Erratum in: J Urol. 2022 Mar;207(3):743. doi: 10.1097/JU.0000000000002436.
Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, Hattat H; Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol. 2002 Mar;41(3):298-304. doi: 10.1016/s0302-2838(02)00027-1.
Zhao B, Hong Z, Wei Y, Yu D, Xu J, Zhang W. Erectile Dysfunction Predicts Cardiovascular Events as an Independent Risk Factor: A Systematic Review and Meta-Analysis. J Sex Med. 2019 Jul;16(7):1005-1017. doi: 10.1016/j.jsxm.2019.04.004. Epub 2019 May 16.
Charalambos Vlachopoulos, Graham Jackson, Christodoulos Stefanadis, Piero Montorsi, Erectile dysfunction in the cardiovascular patient, European Heart Journal, Volume 34, Issue 27, 14 July 2013, Pages 2034–2046
Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):99-109. doi: 10.1161/CIRCOUTCOMES.112.966903. Epub 2013 Jan 8.
Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Ganz P, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug;87(8):766-78. doi: 10.1016/j.mayocp.2012.06.015.
Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011 Sep 20;58(13):1378-85. doi: 10.1016/j.jacc.2011.06.024.
Pozzi E, Capogrosso P, Boeri L, Belladelli F, Baudo A, Schifano N, Abbate C, Dehò F, Montorsi F, Salonia A. Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention? J Sex Med. 2020 Aug;17(8):1489-1494. doi: 10.1016/j.jsxm.2020.03.012. Epub 2020 Apr 24.
Fang SC, Rosen RC, Vita JA, Ganz P, Kupelian V. Changes in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) Survey. J Sex Med. 2015 Jan;12(1):100-8. doi: 10.1111/jsm.12715. Epub 2014 Oct 8.
Sansone A, Cignarelli A, Sansone M, Romanelli F, Corona G, Gianfrilli D, Isidori A, Giorgino F, Lenzi A. Serum Homocysteine Levels in Men with and without Erectile Dysfunction: A Systematic Review and Meta-Analysis. Int J Endocrinol. 2018 Aug 7;2018:7424792. doi: 10.1155/2018/7424792.
Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010 Jan;7(1 Pt 2):445-75. doi: 10.1111/j.1743-6109.2009.01624.x. Erratum in: J Sex Med. 2010 Mar;7(3):1316.
Gandhi J, Dagur G, Warren K, Smith NL, Sheynkin YR, Zumbo A, Khan SA. The Role of Diabetes Mellitus in Sexual and Reproductive Health: An Overview of Pathogenesis, Evaluation, and Management. Curr Diabetes Rev. 2017;13(6):573-581. doi: 10.2174/1573399813666161122124017.
Liao X, Qiu S, Bao Y, Wang W, Yang L, Wei Q. Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials. World J Urol. 2019 Jun;37(6):1061-1074. doi: 10.1007/s00345-018-2583-1. Epub 2018 Dec 6.
Caretta N, de Kreutzenberg SV, Valente U, Guarneri G, Ferlin A, Avogaro A, Foresta C. Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes. Endocrine. 2016 Sep;53(3):831-8. doi: 10.1007/s12020-015-0851-z. Epub 2016 Jan 12.
Binmoammar TA, Hassounah S, Alsaad S, Rawaf S, Majeed A. The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review. JRSM Open. 2016 Feb 12;7(3):2054270415622602. doi: 10.1177/2054270415622602.
Fedder J, Kaspersen MD, Brandslund I, Højgaard A. Retrograde ejaculation and sexual dysfunction in men with diabetes mellitus: a prospective, controlled study. Andrology. 2013 Jul;1(4):602-6. doi: 10.1111/j.2047-2927.2013.00083.x. Epub 2013 Apr 18.
Majzoub A, Arafa M, Al-Said S, Dabbous Z, Aboulsoud S, Khalafalla K, Elbardisi H. Premature ejaculation in type II diabetes mellitus patients: association with glycemic control. Transl Androl Urol. 2016 Apr;5(2):248-54. doi: 10.21037/tau.2016.03.11.
Tajar A, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, Lee DM, Bartfai G, Boonen S, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Vanderschueren D, Wu FC; EMAS Group. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2012 May;97(5):1508-16. doi: 10.1210/jc.2011-2513. Epub 2012 Mar 14.
Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007 Apr;30(4):911-7. doi: 10.2337/dc06-1426.
Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, Saad F, Mannucci E, Maggi M. THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol. 2016 Mar;174(3):R99-116. doi: 10.1530/EJE-15-0262. Epub 2015 Nov 4.
Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology. 2004 May;145(5):2253-63. doi: 10.1210/en.2003-1699. Epub 2004 Feb 5. Erratum in: Endocrinology. 2004 Jul;145(7):3152.
Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, Facchiano E, Sforza A, Forti G, Mannucci E, Maggi M. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013 May 2;168(6):829-43. doi: 10.1530/EJE-12-0955.
Sikka SC, Hellstrom WJ, Brock G, Morales AM. Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med. 2013 Jan;10(1):120-9. doi: 10.1111/j.1743-6109.2012.02825.x. Epub 2012 Sep 12.
Baumhäkel M, Schlimmer N, Kratz M, Hackett G, Jackson G, Böhm M. Cardiovascular risk, drugs and erectile function--a systematic analysis. Int J Clin Pract. 2011 Mar;65(3):289-98. doi: 10.1111/j.1742-1241.2010.02563.x. Erratum in: Int J Clin Pract. 2011 Apr;65(4):516. Hacket, G [corrected to Hackett, G].
Rasmussen L, Hallas J, Madsen KG, Pottegård A. Cardiovascular drugs and erectile dysfunction - a symmetry analysis. Br J Clin Pharmacol. 2015 Nov;80(5):1219-23. doi: 10.1111/bcp.12696. Epub 2015 Jul 28.
Besiroglu H, Otunctemur A, Ozbek E. The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med. 2015 Jun;12(6):1309-18. doi: 10.1111/jsm.12885. Epub 2015 Apr 15.
Gerbild H, Larsen CM, Graugaard C, Areskoug Josefsson K. Physical Activity to Improve Erectile Function: A Systematic Review of Intervention Studies. Sex Med. 2018 Jun;6(2):75-89. doi: 10.1016/j.esxm.2018.02.001. Epub 2018 Apr 13.
Lee Y, Dang JT, Switzer N, Yu J, Tian C, Birch DW, Karmali S. Impact of Bariatric Surgery on Male Sex Hormones and Sperm Quality: a Systematic Review and Meta-Analysis. Obes Surg. 2019 Jan;29(1):334-346. doi: 10.1007/s11695-018-3557-5.
Glina FPA, de Freitas Barboza JW, Nunes VM, Glina S, Bernardo WM. What Is the Impact of Bariatric Surgery on Erectile Function? A Systematic Review and Meta-Analysis. Sex Med Rev. 2017 Jul;5(3):393-402. doi: 10.1016/j.sxmr.2017.03.008. Epub 2017 May 16.
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). / Kostis, J. B.; Jackson, G.; Rosen, R. et al. In: Journal of Urology, Vol. 175, No. 4, 04.2006, p. 1452.
Kloner RA, Goldstein I, Kirby MG, Parker JD, Sadovsky R. Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market. Sex Med Rev. 2018 Oct;6(4):583-594. doi: 10.1016/j.sxmr.2018.03.008. Epub 2018 Jun 28.
Andersson DP, Landucci L, Lagerros YT, Grotta A, Bellocco R, Lehtihet M, Holzmann MJ. Association of Phosphodiesterase-5 Inhibitors Versus Alprostadil With Survival in Men With Coronary Artery Disease. J Am Coll Cardiol. 2021 Mar 30;77(12):1535-1550. doi: 10.1016/j.jacc.2021.01.045.
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000 Dec;12(6):305-11. doi: 10.1038/sj.ijir.3900622.
Capogrosso P, Colicchia M, Ventimiglia E, Castagna G, Clementi MC, Suardi N, Castiglione F, Briganti A, Cantiello F, Damiano R, Montorsi F, Salonia A. One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice. J Sex Med. 2013 Jul;10(7):1833-41. doi: 10.1111/jsm.12179. Epub 2013 May 7.
Corona G, Rastrelli G, Morgentaler A, Sforza A, Mannucci E, Maggi M. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. Eur Urol. 2017 Dec;72(6):1000-1011. doi: 10.1016/j.eururo.2017.03.032. Epub 2017 Apr 20.
Dean RC, Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am. 2005 Nov;32(4):379-95, v. doi: 10.1016/j.ucl.2005.08.007.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61. doi: 10.1016/s0022-5347(17)34871-1.
Gazzaruso C, Coppola A, Montalcini T, Valenti C, Garzaniti A, Pelissero G, Salvucci F, Gallotti P, Pujia A, Falcone C, Solerte SB, Giustina A. Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine. 2011 Oct;40(2):273-9. doi: 10.1007/s12020-011-9523-9. Epub 2011 Aug 23.
Gur S, Kadowitz PJ, Gokce A, Sikka SC, Lokman U, Hellstrom WJ. Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with erectile dysfunction or pulmonary hypertension. Curr Drug Metab. 2013 Feb;14(2):265-9.
Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, McCullough A, Torres LO, Khera M. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 Apr;13(4):465-88. doi: 10.1016/j.jsxm.2016.01.016. Epub 2016 Mar 25.
Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93. doi: 10.1111/j.1365-2265.2005.02339.x.
Saad F, Doros G, Haider KS, Haider A. Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study. Int J Obes (Lond). 2020 Jun;44(6):1264-1278. doi: 10.1038/s41366-019-0517-7. Epub 2020 Jan 28.
Swearingen D, Nehra A, Morelos S, Peterson CA. Hemodynamic effect of avanafil and glyceryl trinitrate coadministration. Drugs Context. 2013 Feb 26;2013:212248. doi: 10.7573/dic.212248.
Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Marchetta M, Maggi M. Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. J Sex Med. 2014 Dec;11(12):2890-902. doi: 10.1111/jsm.12695. Epub 2014 Sep 21.
Yavuz Mert AYDIN. Erektil Disfonksiyon ve Ejakülasyon Bozuklukları: Klinik Yaklaşım. Güncel Üroloji Çalışmaları IX: Klinikte Sık Görülen Ürolojik Hastalıklar Tanı, İzlem ve Medikal Yönetim. Akya Yayınları, 2025; doi: 10.37609/akya.4122.c6698
Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, Qin X, Ren Z, Ding H, Chen Q, Mao C, Tang J. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013 May;63(5):902-12. doi: 10.1016/j.eururo.2013.01.012. Epub 2013 Jan 31.
Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, Lightner DJ, Miner MM, Murad MH, Nelson CJ, Platz EA, Ramanathan LV, Lewis RW. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018 Aug;200(2):423-432. doi: 10.1016/j.juro.2018.03.115. Epub 2018 Mar 28.
Kloner RA, Burnett AL, Miner M, Blaha MJ, Ganz P, Goldstein I, Kim NN, Kohler T, Lue T, McVary KT, Mulhall JP, Parish SJ, Sadeghi-Nejad H, Sadovsky R, Sharlip ID, Rosen RC. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. J Sex Med. 2024 Jan 30;21(2):90-116. doi: 10.1093/jsxmed/qdad163.
Turgut H, Turgut S. Effect of Edentulism and Oral Quality of Life on Sexual Functions in Men: A Cohort Prospective Study. Sex Med. 2021 Apr;9(2):100305. doi: 10.1016/j.esxm.2020.100305. Epub 2021 Jan 30.
